Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 29, 2021

SELL
$3.17 - $4.49 $64,094 - $90,783
-20,219 Closed
0 $0
Q3 2020

Oct 29, 2020

BUY
$2.98 - $5.2 $60,252 - $105,138
20,219 New
20,219 $81,000
Q4 2018

Feb 08, 2019

SELL
$1.59 - $2.66 $308 - $516
-194 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$1.59 - $2.42 $308 - $469
194 New
194 $0
Q2 2018

Aug 13, 2018

SELL
$2.26 - $4.65 $438 - $902
-194 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$3.26 - $4.78 $632 - $927
194
194 $1,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.